Comparing Diabetes Medications, Metformin Offers Cardio Benefits Over Sulfonylureas

A Vanderbilt study examining the impact of the two most commonly prescribed oral diabetes medications on the risk for heart attack, stroke and death has found the drug metformin has benefits over sulfonylurea drugs. It was important to examine the cardiovascular impact of the more commonly used diabetes drugs after recent controversy surrounded another diabetes medication, rosiglitazone, because it was associated with an increased cardiac risk, said lead author, Christianne L. Roumie, M.D., MPH, assistant professor of Internal Medicine and Pediatrics...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/qy7qElLmLzo/252556.php

sport medical sport news news